AKUMIN INC (AKU)       1.01  -0.03 (-2.88%)

1.01  -0.03 (-2.88%)

US01021X1000 - Common Stock


Fundamental Rating

2

Taking everything into account, AKU scores 2 out of 10 in our fundamental rating. AKU was compared to 126 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AKU have multiple concerns. AKU shows excellent growth, but is valued quite expensive already.




Profitability

Profitability Rating

1

The profitability ratios for AKU are negative, so there is not much use analyzing them.
AKU has a Return On Assets of -8.12%. This is below the industry average of -0.48%.

AKU's Profit Margin of -19.73% is worse than the rest of the industry. The industry average Profit Margin is -0.47%.
The Piotroski-F score of AKU is 3.00. This is a low score and indicates issues in the health and profitability of AKU.
VS Industry

ROA (-8.12%) VS Industry: 33% outperformed.

-3,508.17
25.78

Profit Margin (-19.73%) VS Industry: 27% outperformed.

-1,902.40
33.82

Valuation

Valuation Rating

1

Compared to an average industry Enterprise Value to EBITDA ratio of 10.69, AKU is valued in line with its industry peers.
AKU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AKU. No positive earnings are expected for the next year.
VS Industry

Enterprise Value/ EBITDA (10.06) VS Industry: 57% outperformed.

227.82
0.18

Growth

Growth Rating

7

The Earnings Per Share is expected to grow by 38.31% on average over the next 5 years. This is a very strong growth
AKU shows a strong growth in Revenue. In the last year, the Revenue has grown by 148.28%.
The Revenue has been growing by 55.44% on average over the past 5 years. This is a very strong growth!

AKU is expected to show a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 31.63% yearly.
The earnings per share for AKU have decreased strongly by -231.01% in the last year.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -231.01% -297.18% -56.99% 39.64% 38.31%
Revenue55.44% 39.6% 148.28% 85.53% 39.24% 36.94% 31.63%

Health

Health Rating

1

AKU has a Current Ratio of 1.13. This is a normal value and indicates that AKU is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.13 indicates that AKU should not have too much problems paying its short term obligations.
When comparing the Current Ratio of AKU to the average industry Current Ratio of 1.45, AKU is less able to pay its short term obligations than its industry peers.
When comparing the Quick Ratio of AKU to the average industry Current Ratio of 1.31, AKU is less able to pay its short term obligations than its industry peers.

AKU has a negative Debt to Equity ratio (-167.23), which implies it has negative shareholder equity as the company's liabilities exceed its assets. This could be considered a sign of high risk.
Based on the Altman-Z score of 0.33, we must say that AKU is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of AKU to the average industry Altman-Z score of 1.58, AKU is less financially healthy than its industry peers.
The Piotroski-F score of AKU is 3.00. This is a low score and indicates issues in the health and profitability of AKU.
VS Industry

Quick Ratio (1.13) VS Industry: 36% outperformed.

0.02
9.25

Current Ratio (1.13) VS Industry: 29% outperformed.

0.04
9.37

Altman-Z (0.33) VS Industry: 30% outperformed.

-165.85
16.95

Dividend

Dividend Rating

0

No dividends for AKU!.

AKU Daily chart

AKUMIN INC1.01

NASDAQ:AKU (11/28/2022, 11:26:20 AM)-0.03 (-2.88%)

Chartmill FA Rating
GICS Sector Health Care
GICS IndustryGroup Health Care Equipment & Services
GICS Industry Health Care Providers & Services
Earnings (Last) 11-09 2022-11-09/amc Earnings (Next) N/A N/A
Ins Owners 6.54% Inst Owners 25.79%
Market Cap 90.41M Analysts 80
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 0.12 P/B N/A
EV/EBITDA 10.06
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -231.01% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -3368.68%
EPS Next Y -297.18% EPS Next 2Y -56.99%
EPS Next 3Y 39.64% EPS Next 5Y 38.31%
Revenue growth 1Y 148.28% Revenue growth 3Y 39.6%
Revenue growth 5Y 55.44% Revenue growth Q2Q 72.5%
Revenue Next Year 85.53% Revenue Next 2Y 39.24%
Revenue Next 3Y 36.94% Revenue Next 5Y 31.63%
Health
Current Ratio 1.13 Quick Ratio 1.13
Altman-Z 0.33 F-Score 3
Debt/Equity -167.23 WACC 5.38%
ROIC/WACC 1.18
Profitability
ROA -8.12% ROE N/A
ROICexgc 6.33% ROIC 1.5%
PM -19.73% OM 4.19%
Asset Turnover 0.41

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA